Acclerated Reheb & Pain Management Parsippany, NJ - 07054

Acclerated Reheb & Pain Management is categorized under Management Services in Parsippany, NJ and active since 2010.

Acclerated Reheb & Pain Management was established in 2010, and today employs 1 to 4, earning Unknown per year. This is a Management Services business, which does work in the B2B market, and is classified as a Management Services, under code number 6243100 by the NAICS.

If you are seeking more information, feel free to contact Dimitra Pallis, Manager at the company’s single location by writing to 1279 Us Highway 46, Parsippany, New Jersey NJ 07054 or by phoning (973) 588-4493. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Acclerated Reheb & Pain Management
Contact Person: Dimitra Pallis, Manager
Address: 1279 Us Highway 46, Parsippany, New Jersey 07054
Phone Number: (973) 588-4493
Annual Revenue (USD): Unknown
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Management Services
SIC Code: 8741
NAICS Code: 6243100
Share This Business:

Acclerated Reheb & Pain Management was started in 2010 to provide professional Management Services under the SIC code 8741 and NAICS code 6243100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Dimitra Pallis, Manager for inquiries that concern Acclerated Reheb & Pain Management by calling the company number (973) 588-4493, as your correspondence is most welcome. Additionally, the physical location of the single location of Acclerated Reheb & Pain Management can be found at the coordinates 40.86341,-74.39254 as well as the street address 1279 Us Highway 46 in Parsippany, New Jersey 07054.

For its online presence, you may visit Acclerated Reheb & Pain Management’s website at and engage with its social media outlets through on Twitter and on Facebook.